biotech news

[#item_full_content] … [Read more...] about Immunovant Announces Closing of Upsized Common Stock Financing and Full Exercise of Underwriters’ Option to Purchase Additional Shares

[#item_full_content] … [Read more...] about Soleno Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Concurrent Private Placement of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares

[#item_full_content] … [Read more...] about X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

[#item_full_content] … [Read more...] about MDxHealth Announces Proposed Transition to a Sole Listing of Shares on Nasdaq and Convenes an Extraordinary General Shareholders Meeting

[#item_full_content] … [Read more...] about MDxHealth annonce une proposition de transition vers une cotation unique de ses actions sur le Nasdaq et convoque une assemblée générale extraordinaire des actionnaires

[#item_full_content] … [Read more...] about Checkpoint Therapeutics Announces Exercise of Warrants for $11.13 Million in Gross Proceeds

[#item_full_content] … [Read more...] about Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD

[#item_full_content] … [Read more...] about OrphAI Therapeutics Announces Oral Presentation and Posters at the 22nd Annual NEALS Conference

[#item_full_content] … [Read more...] about Klogenix’ pioneering research on age-related diseases and longevity gene Klotho finds new home at ADvantage Therapeutics, Inc.

[#item_full_content] … [Read more...] about ADvantage Therapeutics Welcomes Esteemed Expert in Alzheimer’s Disease and Klotho Protein, Carmela Abraham, Ph.D. as Chief Science Officer